These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13000421)

  • 1. The treatment of streptococcal infections with elkosin N1-(2, 6-dimethyl-4- pyrimidyl) sulfanilamide.
    MOUTON CM; BOWER AG
    J Natl Med Assoc; 1952 Nov; 44(6):435-6. PubMed ID: 13000421
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on absorption, distribution, and excretion of elkosin (N-[2,6-dimethyl-4-pyrimidyl]-sulfanilamide) in man.
    PRIOR JA; SASLAW S
    J Lab Clin Med; 1951 Sep; 38(3):420-7. PubMed ID: 14880757
    [No Abstract]   [Full Text] [Related]  

  • 3. Elkosin in the management of urinary tract infections.
    BOGASH M; ELLIS H; MURPHY JJ
    J Am Med Assoc; 1956 Aug; 161(16):1564-5. PubMed ID: 13345625
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary tract infections: experience with elkosin.
    PHILLIPS CA; LLOYD FA
    J Urol; 1954 Dec; 72(6):1247-54. PubMed ID: 13212949
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfadimetine (elkosin) in ophthalmology.
    HURWITZ P
    Am J Ophthalmol; 1953 Nov; 36(11):1621-3. PubMed ID: 13104575
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy with a new sulfonamide triple mixture; sulfadiazine, sulfamerazine, elkosin.
    LEHR D; TERRANOVA R; BLUMENFELD S; GOLDFARB ML
    Postgrad Med; 1953 Mar; 13(3):231-38. PubMed ID: 13037579
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECTS OF METHENAMINE ON THE METABOLISM OF N1-(2,6-DIMETHYL-4-PYRIMIDINYL) SULFANILAMIDE (SULFISOMIDINE) BY THE RAT AND THE RABBIT.
    DICARLO FJ; HAYNES LJ; SLIVER NJ; COUTINHO CB; PHILLIPS GE
    Chemotherapia (Basel); 1964; 25():255-64. PubMed ID: 14291465
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical experiences with elkosin, 6-sulfanilamido-2-4-dimethylpyrimidine].
    PREUSS HG
    Munch Med Wochenschr; 1950 Nov; 92(31-32):1301-5. PubMed ID: 14796609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of puncture and penicillin or elkosin instillation in purulent puerperal mastitis].
    LEINZINGER E
    Wien Klin Wochenschr; 1952 Jan; 64(4):71-3. PubMed ID: 14913951
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of elkosin on the infected mouse, on the development and oxidation processes of bacteria in the glass in comparison with cibazole].
    FREI W; JEZIERSKI A
    Schweiz Z Pathol Bakteriol; 1946; 9(4):277-90. PubMed ID: 20281315
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical use of sulfisomidine in urinary tract infections.
    RUTENBURG AM
    Ann N Y Acad Sci; 1957 Oct; 69(3):389-94. PubMed ID: 13488267
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of elkosin, gantrisin and sulfacetamide in standardized infections in mice.
    WHITE HJ; WADSWORTH BC; REDIN GS; GENTILE AJ
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):659-77. PubMed ID: 24542157
    [No Abstract]   [Full Text] [Related]  

  • 14. Advent of elkosin.
    BANERJI B
    Ind Med Gaz; 1950 Jul; 85(7):298-302. PubMed ID: 14794175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Frequency of complications in sulfadimethylpyrimidine (elkosin) therapy in 443 cases].
    HARSLØF E; PETERSEN H
    Ugeskr Laeger; 1950 May; 112(19):669-71. PubMed ID: 15443090
    [No Abstract]   [Full Text] [Related]  

  • 16. [New sulfonamide preparations (elkosin, aristamid, mefenal)].
    GRUNKE W
    Ther Ggw; 1951 Nov; 90(11):411-5. PubMed ID: 14893235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Local chemotherapy in diffuse and local appendical peritonitis, with special attention to elkosin].
    HENNICKE W; KERSTNER G
    Z Arztl Fortbild (Jena); 1956 Feb; 50(3):129-33. PubMed ID: 13325572
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative oral toxicity of 6-sulphonamido-2,4-dimethylpyrimidine (elkosin) and of various sulphonamide combinations.
    TRIPOD J
    Arch Int Pharmacodyn Ther; 1953 Jul; 94(3):338-45. PubMed ID: 13093052
    [No Abstract]   [Full Text] [Related]  

  • 19. Conditions contributing to streptococcal virulence; intra-phasic attenuation by sulfanilamide.
    HADLEY P; WETZEL V
    J Bacteriol; 1947 Jan; 53(1):67-81. PubMed ID: 20284951
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria].
    TANNERT S
    Z Gesamte Inn Med; 1952 Nov; 7(22):1042-6. PubMed ID: 13039339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.